ALB - Albemarle Corporation
NEXT EARNINGS:
Apr 29, 2026
(in 25 days)
EPS Est: $1.05
|
Rev Est: $1.3B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$185.93
DETAILS
HIGH:
$216.00
LOW:
$136.00
MEDIAN:
$185.00
CONSENSUS:
$185.93
UPSIDE:
4.40%
Market Cap:
20.99B
Volume:
972,869
Avg Volume:
2,812,822
52 Week Range:
49.43-206
Sector:
Basic Materials
Industry:
Chemicals - Specialty
Beta:
1.48
Last Dividend:
$1.62
Exchange:
NYSE
Country:
US
Employees:
8,300
IPO Date:
1994-02-22
EPS (TTM):
-5.75
P/E Ratio:
-32.60
Revenue (TTM):
5.14B
Total Assets:
16.37B
Total Debt:
3.30B
Cash & Equiv:
1.62B
Rev Growth (5Y):
10.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
2.9%
ROCE:
0.6%
Debt/Equity:
0.35
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-11 | $-0.53 | $-0.42 | -26.8% | $1.4B | $1.3B | +6.0% |
| 2025-11-05 | $-0.19 | $-0.86 | +77.9% | $1.3B | $1.3B | +2.4% |
| 2025-07-30 | $0.11 | $-0.83 | +113.3% | $1.3B | $1.3B | +4.6% |
| 2025-04-30 | $-0.18 | $-0.62 | +71.0% | $1.1B | $1.2B | -7.5% |
| 2025-02-12 | $-1.09 | $-0.60 | -81.7% | $1.2B | $1.3B | -7.8% |
| 2024-11-06 | $-1.55 | $-0.44 | -253.2% | $1.4B | $1.4B | -0.8% |
| 2024-07-31 | $0.04 | $0.53 | -92.5% | $1.4B | $1.3B | +6.9% |
| 2024-05-01 | $0.26 | $0.25 | +2.9% | $1.4B | $1.3B | +5.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.14B | 5.38B | 9.62B | 7.32B | 3.33B | 3.13B | 3.59B | 3.37B | 3.07B | 2.68B | 3.65B | 2.45B |
| Net Income | (510.63M) | (1.18B) | 1.57B | 2.69B | 123.67M | 375.76M | 533.23M | 693.56M | 54.85M | 643.67M | 334.91M | 133.32M |
| EPS | -5.75 | -11.20 | 13.41 | 22.97 | 1.07 | 3.53 | 5.03 | 6.40 | 0.49 | 5.73 | 3.01 | 1.69 |
| Total Assets | 16.37B | 16.61B | 18.27B | 15.46B | 10.97B | 10.45B | 9.86B | 7.58B | 7.75B | 8.16B | 9.62B | 5.22B |
| Total Debt | 3.30B | 3.62B | 4.28B | 3.32B | 2.52B | 3.69B | 3.19B | 1.71B | 1.84B | 2.37B | 3.82B | 2.93B |
| Cash & Equivalents | 1.62B | 1.19B | 889.90M | 1.50B | 439.27M | 746.72M | 613.11M | 555.32M | 1.14B | 2.27B | 213.73M | 2.49B |
| Operating Cash Flow | 1.28B | 687.88M | 1.33B | 1.91B | 344.26M | 798.91M | 719.37M | 546.16M | 303.98M | 733.40M | 360.69M | 492.61M |
| Free Cash Flow | 692.47M | (992.65M) | (827.96M) | 646.20M | (609.41M) | (51.56M) | (132.42M) | (153.83M) | (13.72M) | 536.75M | 133.04M | 382.03M |
| FCF per Share | 5.88 | -8.45 | -7.06 | 5.52 | -5.26 | -0.48 | -1.25 | -1.42 | -0.12 | 4.78 | 1.20 | 4.85 |
| Book Value | 9.53B | 9.96B | 9.41B | 7.98B | 5.63B | 4.27B | 3.93B | 3.59B | 3.67B | 3.80B | 3.25B | 1.36B |
| Cash & ST Investments | 1.62B | 1.19B | 889.90M | 1.50B | 439.27M | 746.72M | 613.11M | 555.32M | 1.14B | 2.27B | 213.73M | 2.49B |
| Return on Equity | -0.05 | -0.12 | 0.17 | 0.34 | 0.02 | 0.09 | 0.14 | 0.19 | 0.01 | 0.17 | 0.10 | 0.10 |